Sjögren's disease & overlap diseases

Efficacy of N-acetylcysteine for treating dryness symptoms of Sjögren's disease: randomised placebo-controlled double-blind clinical study

Clin Exp RheumatolPublished Randomised controlled trial

Authors' conclusion

However, our well-designed study provides novel evidence demonstrating its inefficacy for improving dryness symptoms or reducing oxidative stress.

Study context

Population
Adult Sjögren's disease (SjD) females with low disease activity
Participants
60 adult SjD females
Comparison
N-acetylcysteine (NAC) 1,200 mg/day orally vs placebo
Primary endpoint
Efficacy of NAC for relieving dryness symptoms (EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), Ocular Surface Disease Index (OSDI), Xerostomia Inventory (XI), Leicester Cough Questionnaire (LCQ), salivary flow, Schirmer's test)
Follow-up
D30 and D90
Methodological detailsplacebo-controlled, double-blind
  • Placebo-controlled
  • Double-blind

Primary result

As reported in the abstract

Dryness symptoms (ESSPRI, XI, OSDI, LCQ, Schirmer's test, stimulated salivary flow, ESSDAI, topical/systemic treatments)
  • No significant differences between NAC and placebo (p>0.05)

Further findings

OutcomeP value
Unstimulated salivary flow · D90Significantly higher in the placebo groupP = 0.018
NAC blood concentrations · D30 and D90NAC vs Placebo · D30; significantly higher in the NAC groupP = 0.018
NAC blood concentrations · D30 and D90NAC vs Placebo · D90; significantly higher in the NAC groupP < 0.001
Decrease ≥1 in ESSPRI · D30 and D90NAC vs Placebo · D30 · further analysisP = 0.045
Decrease ≥1 in ESSPRI · D30 and D90NAC vs Placebo · D90; result not found · further analysisP = 0.696

Thiobarbituric acid reactive substances (TBARS) and glutathione

No differences found

Original publication

Efficacy of N-acetylcysteine for treating dryness symptoms of Sjögren's disease: randomised placebo-controlled double-blind clinical study. Clin Exp Rheumatol. Published 13 July 2024. doi:10.55563/clinexprheumatol/dmd5dv

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.